NCT01061957View on ClinicalTrials.gov

Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

December 31, 2009

Conditions
HIV Infections
Trial Locations (1)

2100

The Danish HIV Cohort Study, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Rigshospitalet, Denmark

OTHER

NCT01061957 - Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark | Biotech Hunter | Biotech Hunter